Recent market research analysis by Current Agreements shows that partnering in the last decade has seen an increase in cardiovascular deals with an increase in modern diagnostic technology development. Read the full story

Medtronic bought Cardiocom for $200 million in cash in an M&A deals bid to get into the disease management business. Read the full story

AstraZeneca enters big pharma deals with Par Pharmaceutical Companies for an exclusive U.S. supply and distribution agreement in which Par will distribute the authorized generic version of AstraZeneca's Atacand. Read the full story

SciClone Pharmaceuticals has entered big biotech deals with Zensun Science & Technology granting SciClone the rights to promote, market, distribute and sell Neucardin in China, Hong Kong and Macau. Read the full story

Congestive Heart Failure Partnering provides understanding and access to the congestive heart failure partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story